期刊文献+

高敏C反应蛋白和血浆N末端原脑钠肽对老年心力衰竭患者预后的影响 被引量:18

Study on relationship between changes of hs-CRP and N-terminal pro-brain natriuretic peptide and prognosis in elderly patients with congestive heart failure
下载PDF
导出
摘要 目的探讨高敏C反应蛋白(hs-CRP)和血浆N末端原脑钠肽(NT-proBNP)对老年慢性心力衰竭住院患者预后的影响。方法选择60例慢性心力衰竭的老年人,按照NYHA分级,分为心功能Ⅱ、Ⅲ、Ⅳ级三个亚组,分别测定hs-CRP和NT-proBNP,比较组间的hs-CRP和NT-proBNP变化。再根据住院期间心血管事件发生(急性冠脉综合征、心力衰竭反复加重、死亡)与否,分为心血管事件组和非心血管事件组。比较组间的hs-CRP和NTproBNP的变化。结果心功能Ⅳ、Ⅲ级患者与心功能Ⅱ级患者比较hs-CRP明显升高(P<0.05),NT-proBNP明显升高(P<0.05)。心血管事件组和非心血管事件组比较,心血管事件组的hs-CRP和NT-proBNP高于非心血管事件组(P<0.05)。结论 hs-CRP和NT-proBNP影响老年慢性心力衰竭住院患者的预后,随着心功能级别的加重,免疫炎症反应加剧,心血管事件也在增加。 Objective To explore the effect of serum levels of hs- CRP and N- terminal pro- brain natriuretic peptide on the prognosis of elderly patients with congestive heart failure. Methods A total of 60 elderly patients with heart failure were divided into 2 groups according to the criteria for grades of cardiac function of New York Heart Association( NYHA). The levels of hs- CRPand NT- pro BNP and cardiac events in elderly patients with chronic heart failure were compared. Results The levels of hs- CRP were significantly elevated in patients of NY Ⅳ group and NY Ⅲ group than patients of NYⅡgroup(P〈0. 05). Levels of NT- pro BNP were significantly elevated in patients of NYⅣgroup and NYⅢ group than those of patients in NYⅡgroup(P〈0. 05). The levels of hs- CRP and NT- pro BNP were much higher in patients with cardiac events than those without cardiac events. Conclusion The detection of serum levels of hs- CRP and NT- pro BNP has clinical significance in evaluation of the prognosis of elderly patients with chronic heart failure.
出处 《临床和实验医学杂志》 2017年第1期63-65,共3页 Journal of Clinical and Experimental Medicine
关键词 老年人 心力衰竭 高敏C反应蛋白 血浆N末端原脑钠肽 预后 Elderly Heart failure Hypersensitive-CRP NT-proBNP Prognosis
  • 相关文献

参考文献6

二级参考文献61

  • 1[2]Ridker PM,Glynn RJ,Hennekens CH.C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.Circulation,1998,97:2007~2011.
  • 2[3]Ferranti SD,Rifai N.C-reactive protein and cardiovascular disease:a review of risk prediction and intervention.Clin Chim Acta.2002,317;1~15.
  • 3[4]Hunt SA,Baker DW,Chim MH,et al.ACC/AHA Guidelines for the Evaluation and Management of Chronic heart failure in the Adult..Executive Summary A Report of the American College Of Cardiology/ American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 Guidelines for the Evaluations and Management of Heart Failure).Circulation,2001,104(24):2996~3007.
  • 4[5]Maisel A.B-Type Natriuretic Peptide Levels:Diagnostic and Prognostic in Congestive Heart Failure:What's Next? Circulation,2002 105:2328~2331.
  • 5[6]Berger R,Huelsmann M,Samson S,et al.B-type natriuretic peptide predicts sudden death in patients with chronic heart failure-A selection mode for ICD implantation.J Am Coll Cardiol,2002,39(suppl B):193B.
  • 6[8]Arici M,Walls J.End-stage renal disease,antheroscerlosis and cardiovascular mortality:Is C-reaactive protein in the miss link?.Kidney Int,2001,59:407.
  • 7[9]Werdan K.The activated immune system in congestive heart failure.From dropsy to the cytokine paradigm.J Intern Med 1998,243:87~92.
  • 8[10]Ferrari R,Bachetti T,Confortini R,et al.Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure.Circulation 1995,92:1479~1486.
  • 9[11]MacGowan GA,Mann DL,Kormos RL,Feldman AM,Murali S.Circulating interleukin-6 in severe heart failure.Am J Cardiol 1997;79:1128~31.
  • 10[12]Alonso-Martinez JL,Llorente-Diez B,Echegaray-Agara M,et al.C-reactive protein as a predictor of improvement and readmission in heart failure.Eur J Heart Fail.2002,4(3):331~336.

共引文献4822

同被引文献166

引证文献18

二级引证文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部